Bulldog Investors’s Xynomic Pharmaceuticals Holdings, Inc. Common Stock XYN Stock Holding History

Bulldog Investors’s Portfolio XYN Stock Details XYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$34	–	197
2019 Q2	$34	Buy	+10,000	New	+$32.5K	0.01%	131

Bulldog Investors's XYN Position: Q3 2019 in Review

Bulldog Investors sold out of Xynomic Pharmaceuticals Holdings, Inc. Common Stock (XYN) in Q3 2019, closing a stake of 10,000 shares — an estimated $34 sold.

Bulldog Investors first reported a position in XYN in Q2 2019 and held it in 1 quarter. The position peaked at $34 in Q2 2019. 0 funds tracked by Wall St. Rank hold XYN as of Q3 2019.

Bulldog Investors reported no remaining Xynomic Pharmaceuticals Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Bulldog Investors sold 10,000 Xynomic Pharmaceuticals Holdings, Inc. Common Stock shares in Q3 2019, an estimated $34.
Bulldog Investors first reported a position in Xynomic Pharmaceuticals Holdings, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Bulldog Investors's Xynomic Pharmaceuticals Holdings, Inc. Common Stock position peaked at $34 in Q2 2019.
0 funds tracked by Wall St. Rank held Xynomic Pharmaceuticals Holdings, Inc. Common Stock as of Q3 2019.

Based on Bulldog Investors's 13F filing for Q3 2019, filed 14 Nov 2019.